googlemarker

DR. REDDYS LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 371370.25 Face Value (Rs.) : 5 House : Dr. Reddy's
BSE2239.10-5.6 (-0.25 %)
PREV CLOSE (Rs.) 2244.70
OPEN PRICE (Rs.) 2249.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2239.10 (51)
VOLUME 45003
TODAY'S LOW / HIGH (Rs.)2202.20 2264.75
52 WK LOW / HIGH (Rs.)1901.65 3394.95
NSE2241.55-0.5 (-0.02 %)
PREV CLOSE( Rs. ) 2242.05
OPEN PRICE (Rs.) 2232.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2241.55 (78)
VOLUME 566790
TODAY'S LOW / HIGH(Rs.) 2200.00 2265.00
52 WK LOW / HIGH (Rs.)1901.15 3399.9
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
1007.75
Dividend Yield(%)
0.89
TTM EPS (Rs.)
58.35
P/E Ratio
38.38
Book Value (Rs.)
694.15
Face Value (Rs.)
5
MCap (Rs. in Mn)
371370.25
Price/Earning (TTM)
21.57
Price/Sales (TTM)
3.90
Price/Book (MRQ)
3.23
PAT Margin (%)
14.24
ROCE (%)
11.00
Incorporation Year : 24-02 1984

Management Info :

K Satish Reddy - Chairman GV Prasad - Managing Director

Registered Office :

Address : 8-2-337, Road No. 3,Banjara Hills,,
Hyderabad,
Telangana-500034

Phone : 040 - 4900 2900

Website : www.drreddys.com

Registrars Details :

Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE, NSE, MCX, New York
18Sep Updates
Intimation about audit of our API Mirfield Plant, United Kingdom, by the..
18Sep Dr. Reddy's, Zydus Cadila and Asian Gr
The US Food and Drug Administration (USFDA) has completed the inspection..
16Sep USFDA completes audit at Dr. Reddy’s A
The US Food and Drug Administration (USFDA) has completed the inspection..
QTR Jun 17 ANNUAL 17
Net Profit-7313841
Gross Profit -102 15445
Operating Profit 1972 23368
Net Sales 20897 97198
Rs. in Millions
Abbott India (BSE)
img  4171.40 (2.48%)
M.Cap (Rs. in Cr)8863.93
Hester Biosciences (BSE)
img  929.85 (4.37%)
M.Cap (Rs. in Cr)791.01
Divis Lab (BSE)
img  863.85 (3.61%)
M.Cap (Rs. in Cr)22932.50
SMS Lifesciences (BSE)
img  452.30 (4.99%)
M.Cap (Rs. in Cr)136.74
PROMOTERS
26.78%
NON-INSTITUTION
13.68%
FI/BANKS/INSURANCE
5.95%
MUTUAL FUNDS/UTI
5.79%
GOVERNMENT
0%
FII
0%
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.....Issued in the interest of investors.  |  No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. |  KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Dear Client, Pursuant to SEBI regulation, update your KYC details through KRA form with supporting documents at earliest to complete KYC-KRA requirement. If already submitted, kindly ignore. For any information, in this regard, please contact to our KYC Department on 022-66556772/73/74 or email at kyc@satco.co.in.
  • NSE - INZ 230012635 | 
  • BSE - INZ 010012839 | 
  • MCX - IN2000026431 / FMC : MCX/TCM/CORP/0598  | 
  • NCDEX - IN2000026431 / FMC : NCDEX/TM/CORP/1138 | 
  • CDSL – IN-DP-CDSL-727-2014  | 
  • PMS - INP000003492  | 
  • RESEARCH – INH000002343
  • SATCO CAPITAL MARKETS LTD. All rights reserved. || Designed Developed & Content Powered By Accord Fintech Pvt.Ltd.
VISIT COUNT     290351